Proteomic analysis of induced pluripotent stem cell-derived kidney organoids
Ontology highlight
ABSTRACT: Kidney organoids were generated from a control iPSC line using a previously published protocol (https://doi.org/10.1038/nprot.2016.098). Organoids were collected at three timepoints during the protocol (day 14, 18 and 25) and prepared for proteomic analyses. The focus of the study was to define the proteomic composition of kidney organoids during differentiation with a particular emphasis on the extracellular matrix and its comparison to in vivo systems. Following a ample fractionation and matrix enrichment strategy, samples were prepared for high resolution label-free tandem mass spectrometry to define the proteomic composition of human kidney organoids.
INSTRUMENT(S): Q Exactive HF
ORGANISM(S): Homo Sapiens (human)
TISSUE(S): Kidney
SUBMITTER: Louise Hopkinson
LAB HEAD: Rachel Lennon
PROVIDER: PXD025838 | Pride | 2021-10-13
REPOSITORIES: Pride
ACCESS DATA